• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT PRO PLUS DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT PRO PLUS DCS; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number D-EVPROP2329US
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Intimal Dissection (1333); Low Blood Pressure/ Hypotension (1914)
Event Date 12/18/2019
Event Type  Injury  
Manufacturer Narrative
Other relevant device(s) are: product id: evolutpro-29-us, serial/lot #: (b)(4), ubd: 24-feb-2021, udi#: (b)(4).Product analysis: the delivery catheter system (dcs) and valve were discarded, therefore no product analysis can be performed.Conclusion: without the return of the products, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that during the implant of this transcatheter bioprosthetic valve into a patient with type 0 bicuspid native vale and an aortic root angle of 76 degrees, multiple recaptures were reported due to the challenging anatomy.It was also reported that the implant depth was inadequate, too shallow, therefore multiple recaptures were needed to achieve the proper depth.The valve was ultimately deployed successfully.While removing this delivery catheter system (dcs), and distributing the final dose of contrast under fluoroscopy to check for final valve placement, an aortic dissection was reported.A drop in blood pressure was reported.The patient was urgently transferred to the operating room.The valve was explanted and replaced with a surgical aortic valve, an aortic dissection repair and a coronary artery bypass graft (cabg) were performed.Per the physician, the cause of the aortic dissection was the rub of the dcs along the ascending aorta during the multiple recaptures.It was also reported that the height of the stent frame of the valve caused a larger dissection.Per the physician, both the valve and dcs contributed to the dissection.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT PRO PLUS DCS
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9570135
MDR Text Key187050340
Report Number2025587-2020-00103
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00763000207854
UDI-Public00763000207854
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/27/2020
Device Model NumberD-EVPROP2329US
Device Catalogue NumberD-EVPROP2329US
Device Lot Number0009896247
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2019
Initial Date FDA Received01/09/2020
Date Device Manufactured08/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-